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Abstract: Pharmaceutical pollutants have become a worldwide concern. These emerging contaminants 
(ECs) are ubiquitously found in different water streams with concentrations above ecotoxicity endpoints, 
deteriorating aquatic life and water quality. This study evaluated extensively the efficacy of porous 
graphene (PG) synthesised at relatively low temperature as a potential candidate for the removal of six 
widely utilised pharmaceuticals from their aqueous solutions, such as atenolol (ATL), carbamazepine 
(CBZ), ciprofloxacin (CIP), diclofenac (DCF), gemfibrozil (GEM) and ibuprofen (IBP). Detailed batch 
tests were conducted to investigate the effects of adsorption time, initial EC concentration, PG dosage, 
solution pH, and temperature. Treatment efficiencies of ECs removal by PG were compared with those 
removed by carbonaceous counterparts (graphene oxide and graphite). Mixed solutions of these ECs were 
treated in different water bodies to test PG as a tertiary treatment option. The mechanism of adsorption was 
explored via thermodynamic studies, adsorption kinetics, and isotherm modelling, and characterisation of 
PG sorbent before and after ECs adsorption using TEM, SEM-EDS, XRD, FT-IR, Raman spectroscopy and 
other analyses. The results revealed fast kinetics and adsorption capacities exceeding 100 mg-EC/g-PG for 
some of ECs, and high removal efficiencies for trace concentrations of ECs (>99%) at a low dose of PG 
(100 mg/L). Removal efficiencies of mixed ECs in water and wastewater samples suffered from negative 
interferences, which can be mitigated by increasing the PG dosage. Adsorption processes were 
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heterogeneous and controlled by physisorption. Further results showed the exothermic nature of the 
enthalpy-driven adsorption process and the recyclability potential of PG. It can be considered that PG could 
be used as a promising candidate for efficient treatment of water contaminated with ECs related to the 
pharmaceutical group. 
Keywords: Emerging contaminants; Pharmaceuticals; Graphene-based materials; Porous graphene; 
Adsorption; Wastewater treatment 
1 Introduction 
Pharmaceuticals have emerged as potential emerging contaminants (ECs) over the last two decades. Their 
traces are rampant in ground and surface waters, typically at trace levels from ng/L to low µg/L, and even 
can be omnipresent in drinking waters [1, 2]. Their existence in drinking water has raised great concerns 
regarding the long-term deleterious risks they might pose to human health and aquatic ecosystems [3]. 
Pharmaceuticals are originated from human and veterinary drugs and food additives and are generated into 
the environment initially via human or animal excreta with little or no change to their chemical structure 
[4]. Surface waters, groundwater and partially treated water contain pharmaceutical traces typically less 
than 100 ng/l, while treated water has concentrations generally below 50 ng/l [5]. However, evidence on 
their detection and persistence in various natural freshwater resources is increasing worldwide. According 
to Fekadu et al. (2019), several pharmaceuticals were present in aquatic environments of both Africa and 
Europe in concentration levels higher than their ecotoxicity endpoints [6]. Pharmaceuticals are generally 
well characterised, and their impacts are assessed before commercialisation, so their negative effects are 
expected to result in the endocrine disruption in living organisms and development of antibiotic-resistant 
bacteria and genes [1, 7].  
Pharmaceuticals commonly found in water streams in India and the UK, such as atenolol (ATL), 
carbamazepine (CBZ), ciprofloxacin (CIP), diclofenac (DCF), gemfibrozil (GEM) and ibuprofen (IBP), 
were selected as model compounds for this study. ATL belongs to a class of pharmaceutical compounds 
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known as beta-blockers, used to treat high blood pressure and heart rhythm disorders [8]. This class of drug 
is not effectively removed during wastewater treatment, characterised by long half-life (up to 166 days) and 
detected in various environmental water samples (varying from non-detected to 11 μg/L) [9]. 
Comparatively, CBZ is an antiepileptic drug that is most widely consumed to treat seizure disorders and 
relieve specific types of nerve pain such as trigeminal neuralgia [10]. It inhibits human embryonic cell 
growth [11] and bioaccumulates in freshwater and marine species, such as algae, bacteria, fish, and 
gastropods [12]. Among antibiotics, CIP is a highly used second-generation fluoroquinolone antibiotic [13]. 
The existence of this antibiotic in the environment can cause adverse effects to the microbial communities, 
leading to disturbances in the ecosystem [14]. DCF is a nonsteroidal anti-inflammatory drug (  used 
for pain and joint stiffness relief. However, it was reported that, with chronic human exposure, DCF may 
result in thyroid tumours and hemodynamic changes [15].  IBP is another widely used medication and is 
one of the top five most commonly consumed drugs in the UK [16]. IBP causes serious side effects to the 
human body including vomiting, bleeding, kidney problems, and cardiovascular risks [17, 18]. Finally, 
GEM is a fibrates-type drug used to help lower fats (triglycerides) by reducing "bad" cholesterol (low-
density lipoprotein) and raising "good" cholesterol (high-density lipoprotein) in the blood [19]. Like others, 
its presence in water might have environmental risks to humans, which are still unknown, and to marine 
organisms such as reducing testosterone levels in goldfish [20]. Numerous studies have proved that these 
contaminants are ubiquitously found in different aquatic environments and detected frequently in drinking 
waters with concentrations above ecotoxicity endpoints due to their poor metabolism and slow 
biodegradation [17, 21-24]. Therefore, it is crucially important to design an appropriate technology that can 
cost-effectively achieve high removal rates and uptake capacities for these pharmaceuticals.  
The wastewater and drinking-water treatment processes were not designed specifically to eliminate 
pharmaceuticals [5]. Therefore, strategies for the removal of pharmaceuticals from drinking water have 
been broadly explored. Advanced wastewater treatment processes (e.g., advanced oxidation, adsorption 
using activated carbon, ozonisation, nanofiltration membrane and reverse osmosis technologies) offer high 
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removal rates (above 99%) for targeted pharmaceutical compounds [5, 25]. Concerns are raised about the 
cost-effectiveness of these tertiary treatment processes. Most of them incur high costs and generate 
undesirable by-products. Of the above-mentioned techniques, adsorption seems to be a promising cost-
effective technique for the removal of pharmaceuticals. It is simple to design and operate, has a low 
implementation cost compared to other technologies, offers high probability of recycling spent adsorbents 
and does not generate toxic by-products [26].  
As far as adsorption and effective nano-adsorbents are concerned, graphene is an ideal nano-adsorbent for 
water treatment owing to its high theoretical specific surface area (SSA, 2630 m2/g) and the presence of 
two basal planes of its single layer, available for contaminant adsorption [27]. In addition, the highly 
hydrophobic surface of graphene attracts organic contaminants with a strong adsorption affinity, such as 
chlorobenzenes, phenols, dyes and other toxic organic pollutants [28-30]. The removal of most under-
investigated ECs (e.g., ATL, CBZ, CIP, DCF, and IBP) from water is mainly dominated by graphene oxide 
(GO) in literature [18, 31-34]. GO has a nanosheet surface decorated with oxygen-containing functional 
groups (OCFGs) that results in a good hydrophilic characteristic and increased adsorptive affinity towards 
polar contaminants. However, in terms of higher surface area, superhydrophobicity, ease of separation from 
water, recyclability and chemical stability, porous graphene is a more attractive candidate for ECs removal, 
especially when it is produced by a low-cost scalable synthesis method [35, 36]. In this regard, the reported 
technique used in this study for preparing PG structure was innovative as it only involved two steps after 
the preparation of GO, which did not involve the addition of a catalyst or use of any template [36]. 
Additionally, the temperature range involved was 190–200 °C, which was lower than that previously 
reported for the synthesis of porous rGO [37]. In terms of application, up until now the treatment using 
graphene material has not been fully recognised for some of these contaminants (e.g., GEM). There have 
been only limited studies about the treatment of the considered ECs using graphene [38, 39] in either single 
or mixed solution in different water matrices and the recyclability study was not provided.  
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The present work aims to test the adequacy and efficacy of a novel porous-type graphene material, 
synthesised at relatively low temperature, for ECs removal from water and uncover controlling mechanisms 
of the treatment. For that purpose, porous graphene (PG) with high SSA (679 m2/g) was synthesised via a 
facile cost-effective route. The as-prepared PG and GO were used for the adsorption/removal of ATL, CBZ, 
CIP, DCF, IBP, and GEM drugs from aqueous media. All resemble different chemical structures and 
physicochemical properties in terms of hydrophobicity and hydrophilicity. The performance of the 
suggested graphene-based materials (GBMs) for the decontamination of six ECs was evaluated under 
different conditions of adsorbent dosages, single or mixed solution system, water bodies, contact time, pH 
and temperature. As-prepared and spent particles of PG were characterised by Fourier transform infrared 
(FT-IR), X-ray diffraction (XRD), Scanning electron microscopy – energy-dispersive X-ray spectroscopy 
(SEM-EDS), transmission electron microscopy (TEM), and Raman spectroscopy analyses for clarifying 
the sorption mechanisms. Furthermore, adsorption isotherms and kinetics of the nano-adsorbents were 
studied using different thermodynamic and kinetic models and discussed to elucidate the adsorption 
behaviour. In addition, mechanisms and spontaneity of ECs adsorption were further illustrated by 
calculating the thermodynamic parameters. Finally, the recyclability of PG was addressed and assessed in 
several cycles for reliable application purposes. 
2 Materials and Methods 
2.1 Chemicals, adsorbates and adsorbents preparation  
Graphite (GI) powder (~20 µm), NaNO3, H2SO4 (95.0-98.0%), KMnO4, H2O2 (30 wt%), hydrazine (35 
wt%), and analytical grades of pharmaceuticals, including ATL, CBZ, CIP, DCF sodium, GEM and IBP, 
were purchased from Sigma-Aldrich Co. (Poole, Dorset, UK), and sodium hydroxide and hydrochloric acid 
(36 wt%) were provided by Fisher Scientific Ltd. (Loughborough, UK).  
PG was synthesised following the procedure reported previously by us [36], based on an inexpensive 
chemical oxidation – exfoliation – reduction – thermal treatment protocol. In brief, exfoliated graphene 
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oxide flakes (around 1.5 nm in thickness, 0.5-20 µm in lateral size) were prepared following the modified 
Hummers’ method. Initially, graphite flakes were oxidised by concentrated H2SO4, in the presence of 
NaNO3, H2O2, and KMnO4 as catalysts. The resultant graphite oxide was exfoliated and sonicated for 2 hrs 
in 500 mL suspension. 150 mL of GO solution was reduced by adding hydrazine (3 mL) in two stages 
(durations of 12 hrs and 2 hrs). The resultant reduced graphene oxide (rGO) particles were vacuum filtered, 
washed with distilled water (200 mL) and thermally-treated by drying overnight at 200 oC under vacuum.  
The pharmaceuticals were used to prepare standard stock solutions of ECs. All stock and standard solutions 
were prepared using distilled water (DW). NaOH and HCl were used to adjust the pH of the prepared ECs 
solutions. All the solutions were surrounded by aluminium foil during storage and tests to prevent photo-
degradation of the ECs. Suspensions of GI, GO and PG were sonicated for 10 min prior to their application 
in batch experiments. 
2.2 Batch tests 
Batch adsorption tests were carried out for each individual emerging contaminant under different conditions 
as illustrated below. All tests were repeated thrice, and the average values were taken for data analysis 
(supplementary information, SI 1), which comprises kinetic modelling (SI 1.1), adsorption isotherm 
modelling (SI 1.2), and adsorption thermodynamics (SI 1.3).  
2.2.1 Contact time  
Kinetic studies were performed using EC initial concentration (C0) of 10.5 mg/L (stock solution) for 
different contact-time intervals in separate experiments at room temperature (22 ± 3 oC) without pH 
adjustment (pH0 ≈ 7.5). 20 mL of pharmaceutical solution (ATL, CBZ, CIP, DCF, GEM or IBP) were 
placed in 60 mL bottles with screw caps. A certain amount of GI, GO or PG (5 mg from a suspension of 5 
g adsorbent/L) was added into EC solution, followed by magnetic stirring/mixing for predetermined periods 
(t = 10, 20, 30, 50, 70, 90, 120, 240, or 300 min). The collected samples were filtered immediately through 
a 0.2 µm membrane filter.  
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2.2.2 Equilibrium experiment 
Batch tests were carried out to evaluate the effects of variation in initial EC concentration (0.1-100 mg/L 
for ATL, CBZ, CIP, DCF, 0.1-15 mg/L for GEM, and 0.1-21 mg/L for IBP) using a fixed dosage of 
adsorbent (5 mg GI, GO or PG injected from a 5-g/L suspension). A mixture of pharmaceutical (20 mL) 
and graphite or GBM were shaken in 50 mL centrifuge tubes on a rotary shaker for 24 hrs. The supernatants 
of samples were acquired after vacuum filtration. Additionally, the effects of adsorbent dose variations of 
PG were explored by injecting specific amounts of 5-g/L PG suspension (0.1-2 mL) into a certain 
concentration of EC single solution, so that the initial concentration of EC after PG suspension addition 
was adjusted to 1 mg/L. Real sample investigations were carried out by applying the same specific amounts 
of 5-g/L PG suspension (0.1-2 mL) into ECs mixed solution spiked into distilled water (DW) or wastewater 
(WW) body. The initial concentration of each EC was set to 1 mg/L in either DW or WW. The domestic 
wastewater (partially treated) sample was collected from the final settlement tank of the secondary 
treatment unit prior to tertiary biological aerated flooded filter (BAFF) treatment unit, existing at Countess 
Wear Wastewater Treatment Works, South West Water Co., Exeter, Devon, UK. The characteristics of the 
WW sample are shown in Table S1. The collected WW sample was modified to contain ECs mixed solution 
and used immediately within one week after collection. If stored during that period, it was kept under 5 oC 
in a cold store. 
2.2.3 Effect of pH and temperature  
Batch adsorption tests were carried out for each EC under different pH and temperature conditions in 20 
mL pharmaceutical solution of 10 mg/L with added PG (5 mg). In the cases of batch tests for the pH effect, 
the initial pH of EC solutions was adjusted to a specific value using (0.1 or 1 M) NaOH or HCl solutions 
and batch tests were conducted at room temperature (22 ± 3 oC). The pH of the solution after treatment was 
measured and found to be unchanged. The resulting suspensions of different pH values (2-11) were stirred 
on hotplate stirrers for 2 hrs at 200 rpm and the processed samples were separated via filtration using 0.2 
µm membrane filter. To investigate the effect of temperature variation on adsorption, the pH of the solution 
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was maintained at neutral level and tests were conducted at various temperatures (10-90 oC) under similar 
conditions described above (in 10 mg/L-EC solution of 20 mL volume treated with 5 mg-PG and stirred at 
200 rpm for 2 hrs). 
2.2.4 Reusability study 
To evaluate the recyclability and reusability of PG, regeneration cycles were repeated four times. The 
conditions of the adsorption experiment were set at 5 mg PG dosage, 20 mL EC of 10 mg/L, 2 hr contact 
time, 200 rpm stirring speed and room temperature. After sampling, the PG particles were allowed to settle, 
and the supernatant was withdrawn via a peristaltic pump. The spent particles were washed with DW and 
then subjected to a desorption process. NaOH solution (1 M) was applied as the desorption agent to recover 
ECs from the spent PG and the reaction mixture was stirred at 90 oC for 2 hrs. Subsequently, PG particles 
were rinsed twice with water and ethanol, and applied for a new cycle of adsorption. The regenerated nano-
adsorbent was used for subsequent adsorption cycles under similar adsorption conditions to those in the 
case with the freshly prepared PG.  
2.3 Analytical Methods 
2.3.1 Characterisation techniques 
GBMs (pre-adsorption samples) and spent PG particles (as post-adsorption samples) were characterised by 
SEM-EDS, TEM, XRD, FT-IR, Raman spectroscopy, and surface characterisation analyser. 
The morphologies of GI, GO and PG samples were examined using SEM-EDS (TESCAN VEGA3 SEM 
fitted with X-MAXN EDS detector) under high vacuum condition with accelerating voltage 20 kV. For 
GO, images were acquired from gold-coated samples and all the samples were mounted onto conductive 
carbon adhesive tapes. 
High-resolution nanostructural images of as-prepared GO and PG were taken using a JEOL-2100 
transmission electron microscope (TEM) operating at an accelerating voltage 200 kV. The powder sample 
9 
 
was dispersed in ethanol and then dropped on the centre of a holy carbon-coated copper grid using a 
micropipette.  
For FT-IR measurements, Infrared (IR) absorbance spectra were obtained between 500 and 2000 cm-1 at a 
resolution of 4 cm-1 using 20 co-added scans. 5 mg of material particles were thoroughly mixed with 180 
mg of potassium bromide (KBr) in an agate mortar. Pellets were formed by pressing the resulting mixtures 
under 5 tons for 2 min. Each pellet was placed into an attachment and then analysed in the optical 
compartment of FT-IR instrument. 
Nanocrystalline composition of samples was determined by XRD analysis performed with an X-ray 
diffractometer from Bruker (D8 advanced). XRD patterns were recorded using Cu Kα radiation at 40 kV 
and 40 mA over 2θ range of 10-50o with a scan rate of 2° (2θ). Additionally, the Raman spectra were 
acquired using laser excitation of wavelength 532 nm operated at 6 mW power and emitted from Renishaw 
RM-1000 diode as a continuous wave.  
The N2 adsorption Brunauer-Emmett-Teller (BET) method was used to determine the SSA, porosity, pore 
volume and pore size of the PG. The nitrogen gas sorption analysis was carried out using a Quantachrome 
Autosorb-iQ gas area characterisation analyser. PG samples were heated to 200˚C under vacuum for 4 hrs 
to remove any contaminants inside pores prior to cooling in an external bath to -195.8˚C (77.2 K). Nitrogen 
gas was introduced to the evacuated sample chamber where the pressure and the total volume of gas were 
measured. The results from the gas sorption experiment are presented as a nitrogen adsorption-desorption 
isotherm curves in a graph, presenting the amount of gas adsorbed against the relative pressure in the 
chamber. For further inspection, the particle size and zeta potential were measured using Zetasizer Nano 
ZS (Malvern Panalytical Ltd, Malvern, UK) to further characterise PG and investigated ECs at the pH of 
the adsorption.  
 The wettability of GO, PG and ECs samples was examined using a contact angle goniometer. Images of 
each droplet were captured on a digital camera and analysed using the contact angle plugin in the software 
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ImageJ. The contact angle value indicates the hydrophobicity of the material: hydrophobic in the case of 
>90˚ and hydrophilic in the case of < 90˚[40]. 
2.3.2 Measurement of ECs concentrations in solutions 
A UV–vis absorption spectrophotometer was used to measure ATL, CBZ, CIP, DCF, GEM and IBP sample 
concentrations at 226, 285, 272, 275, 220 and 221 nm, respectively [18, 38, 41-44]. In addition, EC samples 
of lower concentrations (below 1 mg/L) were measured using Liquid Chromatograph (LC) equipped with 
a mass selective (MS) detector. Quantitative analysis of these six pharmaceutical drugs was performed 
using an Agilent 6420B triple quadrupole (QQQ) mass spectrometer (Agilent Technologies, Palo Alto, 
USA) hyphenated to a 1200 series Rapid Resolution HPLC system. 5 µl of the sample was loaded onto an 
Eclipse Plus C18 3.5 µm, 2.1 x 150 mm reverse-phase analytical column (Agilent Technologies, Palo Alto, 
USA). For detection using negative ion mode, mobile phase (A) comprising 100% LC-MS grade H2O, with 
0.1% formic acid and mobile phase (B) was 100% acetonitrile (LC-MS grade).  The following gradient was 
used: 0 min – 20% B; 4 min – 90% B; 8 min – 100% B; 10 min – 100% B; 11 min – 20% B followed by 4 
min re-equilibration time. The flow rate was 0.3 mL/min and the column temperature was set at 30 °C for 
the duration. The QQQ source conditions for electrospray ionisation were as follows: gas temperature 350 
°C, drying gas flow rate of 11 L/min, nebuliser pressure 35 psig, and capillary voltage 4 kV. All ions were 
scanned in the negative ion mode and for a dwell time of 30 mseconds. The fragmentor voltage and collision 
energies had previously been optimised for each compound and are listed in Table 1, along with the 
compound retention times (RT) (in minutes), based on initial guidelines shown in previous reports [45, 46].  
Data analysis was undertaken using the Agilent Mass Hunter Quantitative analysis software for QQQ 
(version B.09.00).  Concentrations were calculated from the standard concentration curves in the range of 
1 mg/L to 0.06 µg/L, as were the limits of quantification (LOQs) for each compound (also in the table 
below).  Four replicas were used for each test condition and the averages compared. 
Table 1.  Target compounds and their structures, main m/z ions, fragmentor and collision energy voltages, average 
retention time and limits of quantification (LOQ) for LC-MS analysis. 
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3 Results and Discussion 
3.1 Adsorption batch studies 
3.1.1 Effect of contact time and ECs adsorption kinetics 
Batch tests were conducted for different contact times to acquire kinetic profiles for the six ECs adsorbed 
onto GI, GO and PG (Fig. 1). Fast sorption kinetics was observed in the initial stage of adsorption (60 min) 
for most of the ECs. Then the rate of adsorption decreased upon further increasing the time. The results 
indicated the outperformance of PG in overall, achieving removal efficiency of ECs above 40 to 60%. 
Hence, PG was found to be highly efficient for ECs removal in extremely low dosage (250 mg/L).  The 
applied dosage is significantly low compared to that applied dosage for efficient pharmaceutical 
decontamination in other studies, involving treatment using activated carbon (e.g., 3000 mg/L on average 
[2] and above 5000 mg/L [47]). To illustrate the sorption mechanism and the role of surface area and active 
sites, four kinetic models (SI 1.1) including pseudo-first order, pseudo-second order, Elovich and 
intraparticle diffusion reaction models were applied to evaluate the rate of adsorption reaction and its rate-
controlling step. Of the four suggested models, the pseudo-second order rate model best described the 
kinetics of ECs adsorption onto GO and PG with an excellent fit as indicated by the highest correlation 
coefficient values (R2 = 0.99 for most ECs). Table 2 lists the kinetic parameters and values of regression 
correlation coefficients (R2) for each model. Kinetics of adsorption could be related to the 
hydrophilicity/hydrophobicity of EC, which is indicated by n-octanol/water partitioning coefficient (KOW) 
[34].  According to the log value of n-octanol/water partition coefficient (Log KOW values) for ECs shown 
in the surface wettability results (section SI 2.2), ATL and CIP are hydrophilic compounds with more 
OCFGs (e.g., carbonyl and hydroxyl groups). This facilitates faster access to the active sites and oxygen 
moieties on GO surface compared with adsorption on the superhydrophobic surface of PG. Therefore, 
values of kinetic constant of pseudo-second order model for ATL and CIP adsorption are two orders and 
one order of magnitude higher than that of PG, respectively.  On the contrary, rapid adsorption kinetics rate 
was recorded for the rest of ECs onto PG due to their hydrophobic interactions as IBP and GEM are 
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hydrophobic contaminants and CBZ is slightly hydrophilic/hydrophobic in nature. Such hydrophobic 
interactions/effects between hydrophobes and water cause hydrophobes (PG and EC of hydrophobic nature) 
to be attracted to each other and oriented away from water [48].  
Fig. 1. Effect of contact time on adsorption of ATL, CBZ, CIP, DCF, IBP and GEM onto GI, GO and PG. Error bars 
were calculated based on standard deviation (Experimental conditions: number of runs 3; C0 10 mg/L; adsorbent 
dosage 250 mg/L; pH 7.5; temperature 22 ± 3 oC). Graph dots and lines represent experimental results and their 
moving average fitting, respectively, and error bars indicate standard error of three replicates. 
Table 2. Values of fitted kinetic parameters for ECs adsorption by PG and GO (10 mg/L initial EC concentration, 
adsorbent dosage 250 mg/L, pH 7.5, temperature 22 ± 3 oC). 
3.1.2 Effect of adsorbate initial concentration and ECs adsorption isotherms  
Equilibrium studies were conducted to reveal the effect of initial EC concentration on the process of 
adsorption onto GI, GO and PG. Fig. 2 presents the isothermal data of ECs adsorption, revealing the 
relationship between equilibrium adsorption capacities of GI, GO and PG for ECs and concentrations of 
ECs in aqueous solutions at equilibrium. The isothermal experiments were carried out at room temperature 
(22 ± 3 oC) and with a mass of adsorbent of 5 mg (fixed dosage 250 mg/L). The results indicated further 
affinity of ECs of hydrophilic nature, such as ATL and CIP towards GO, while the other ECs were more 
attracted to PG and to a lower extent to GI. It should be noted that PG performance was not far poorer than 
that of GO, as indicated by the maximum adsorption capacities of GO and PG (calculated from batch test 
results) for ECs listed in Table S2. In general, although the adsorption performance of GO was higher for 
ATL and CIP removal, but, in terms of superhydrophobicity, ease of separation from water, recyclability 
and chemical stability, PG is a more attractive candidate for ECs removal in water treatment applications 
[36, 49]. Thus, PG nanosheets outperformed their GBM counterparts. To elucidate further, seven adsorption 
isotherm models were evaluated for best fit to the experimental data. The calculated parameters of these 
models (Eqs. (S6-S12) in SI 1.2), including maximum adsorption capacities (qs), are given in Table 3. In 
terms of the best match criterion (R2), the Sips and Toth models are more appropriate for describing the 
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adsorption equilibrium data for ECs onto GO and PG. Also, adsorption results of GO for ATL and CBZ 
could be depicted by the Freundlich model (Table 3), which agrees with that reported previously [31, 34]. 
These results indicated heterogeneous adsorption arising from the distribution of surface sites which varied 
in abundance, type and strength for GO that resulted from the presence of OCFGs, planar surface and edge 
sites, and possible zones of different polarizability. However, PG adsorption performance for ATL, CIP, 
CBZ, DCF, and GEM and that of GO for ATL, CIP and GEM follows the Toth model. As stated earlier, 
the Freundlich and Toth isotherm models are plausible for describing heterogeneous multilayer adsorption. 
IBP adsorption data for GO and PG is represented by the Langmuir isotherm similar to what was reported 
in conducted studies on GO [18]. This seemed to suggest that, in the case of IBP adsorption onto a GBM 
surface, a monolayer coverage was formed, implying that the binding energy of each IBP molecule on the 
surface GO was uniform. Hence it is concluded that the GO molecules did not interact with one another 
during the IBP adsorption. Finally, in the case of DCF adsorbed by GO and PG, it was found that the Toth 
and Langmuir models fairly yielded a better fitting than the other models. In all cases, the value of the main 
energy of adsorption E (kJ/mol), which is related to the D-R model, can predict the type of adsorption. The 
observed low values of E parameter in Table 3 indicated that ECs adsorption process on GO and PG 
demonstrated physical characteristics [50].  
Fig. 2. Adsorption isotherms of six investigated ECs onto G, GO and PG. Solid lines represent suggested model 
simulation. Experimental conditions: 250 mg/L adsorbent, pH 7.5, temperature 22 ± 3 oC.  
Table 3. Equilibrium parameters for the adsorption of ATL, CIP, CBZ, IBP, DCF and GEM onto PG and GO. 
Experimental conditions: 250 mg/L adsorbent, pH 7.5, temperature 22 ± 3 oC. 
3.1.3 Effect of adsorbent dosage on ECs removal in single and mixed solution 
Fig. S1 illustrates the effect of PG dosage (25 - 500 mg/L) on the trace concentration of ECs, revealing that 
with increasing the dosage of PG, the concentrations of ECs dropped significantly (below 5 µg/L), 
especially after 100 mg/L of PG dose. Such improved removal performance is attributed to the availability 
of more active and accessible adsorption sites with higher dosages. In addition, PG can be considered a 
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formidable remediator capable of treating these ECs even in real mixed solution (e.g. drinking water 
contaminated with ECs mixture) due to the low concentrations of ECs in actual drinking water and the high 
reactivity of PG nanosheets.  
The applicability of PG to the removal of the selected pharmaceutical ECs was further investigated as a 
tertiary treatment option if used as an adsorbent in treating ECs mixtures in DW and WW matrices. Initially, 
the concentration of pharmaceuticals in the collected WW sample could not be detected by LC-MS analysis 
(below detection limit). Afterward, two water bodies (DW and WW) were spiked with the selected ECs to 
obtain final concentrations of 1 mg/L for each EC. These mixtures could be considered as real 
environmental aqueous samples, especially WW samples. Then PG was applied to these samples with 
various dosages (25-500 mg/L) and its treatment/concentration profiles are shown in Fig. 3. In general, the 
presence of all ECs in one medium (DW or WW) affected the removal of each EC by PG, so the 
concentrations of treated mixed solution samples were higher than that of treated EC (single) solution 
samples. This should be attributed to the competition between these drugs to occupy the active adsorption 
sites of PG, which resulted in a general negative interference effect. Such effect was often observed in 
numerous studies that dealt with real sample investigations [33, 39, 51-55].  A significant increase in EC 
concentration appeared in mixed ECs solution of DW matrix after treatment apart from CIP for which the 
removal performance of PG was not drastically degraded. According to Tables S2 and 3, CIP has the highest 
affinity among other selected ECs towards PG with maximum adsorption capacity of ca. 370 mg-CIP/g-PG 
(Sips model, R2=1). Such affinity of CIP is shown clearly in Fig. 3 where the negative interference effect 
on PG removal performance for CIP in mixed solution compared to that for CIP in single solution (both in 
DW body) was minimum. On the contrary, the treatment of IBP in mixed solution samples has shown the 
highest final concentrations, lowest treatment efficiencies and strongest negative interference, due to the 
lowest maximum IBP adsorption capacity (compared to that of other ECs) of PG of ca. 48 mg/g (Table 3, 
Langmuir isotherm, R2= 0.98). One way to improve the treatment efficiencies of ECs mixed in DW samples 
is to increase the dose of PG around 5 times. 100 mg/L of PG was sufficient to treat concentrations of ECs 
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(1 mg/L) single solutions with removal efficiencies above 99%. From Fig. 3, raising the dosage of PG to 
500 mg/L improves the removal efficiencies of ATL, CBZ, CIP, DCF, GEM and IBP to 99.6%, 99.2%, 
99.9%, 99.8%, 99.7% and 88.2%, respectively. 
Fig. 3. Effect of adsorbent dosage on the removal of EC in distilled water and wastewater bodies (single or mixed 
solution, contact time: 24 hrs; pH (DW) 7.5; pH (WW) 7.1; initial individual EC concentration in single or mixed 
solution: 1 mg/L). Error bars indicate standard error of four replicates. 
Similarly, treated samples of ECs mixed and spiked into WW body suffered an increase in EC concentration 
if compared to the concentration of treated EC single aqueous solution (Fig. 3). The modified wastewater 
samples contained mixed ECs and were rich in ammonia and chlorides (as indicated in Table S1), which 
could influence the adsorption process by PG. Nevertheless, on the contrary, Fig. 3 indicates that treated 
real environmental samples of WW have shown lower concentrations compared with treated mixed ECs of 
DW for most of the ECs. It should be noted that the withdrawn WW samples were collected from the final 
settling tank of the secondary treatment unit just before BAFF treatment, which involves a sort of biological 
remediation. Therefore, the WW sample enclosed microbial content and these targeted ECs are mainly 
organic compounds and could still be removed to various degrees by any bacterial action. For instance, 
biological treatment has various removal rates for pharmaceuticals ranging from less than 20% to greater 
than 90% depending on several factors including sludge age, activated sludge tank temperature and 
hydraulic retention time [5]. In spite of the fact that GBMs have developed a demonstrated antibacterial 
activity [56], it might be difficult to eliminate the whole microbial content given that the PG dose was 
significantly low, and different competing organic contaminants, ammonium ions , chloride ions and other 
ions were present to interfere with PG bactericidal activity. As being an antibiotic, CIP could resist that 
bacterial action and its concentrations in the treated WW samples were relatively higher than CIP 
concentrations in single or mixed solution of DW background. In addition, the effect of the ionic strength 
on the adsorption of CIP onto graphene and graphene oxide was explored and the presence of chloride ions 
caused a decline in their adsorption capacity [33, 39]. It was suggested that the possible reasons for such 
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lower performance were attributed to the electrostatic screening of concentrated cation ions (Ca2+, Na+ 
accompanying chlorides) and the salting-out effect that could reduce the solubility of CIP in water and 
encourage hydrophobic partitioning of CIP to graphene.  
Regarding the treatment performance of PG in pharmaceuticals contaminated wastewater samples, the 
reduction in removal efficiency is generally lower than that in DW samples containing mixed contaminants. 
This observation indicates that the performance of PG would be refined and improved by utilising an excess 
dosage of PG lower than that used for mixed ECs solution of DW samples. From the graphs in Fig. 3, 
applying around 2.5 times the dose of PG suggested for single EC in DW matrix (equivalent to 250 mg/L) 
would be sufficient to reduce ECs concentrations significantly (below 15 µg/L).  
3.1.4 Effect of pH on adsorption of ECs onto PG 
The effect of pH on ECs adsorption onto PG was investigated, and ECs concentration profiles are shown 
in Fig. 4. When pH < 8, there was no significant change in the final concentration of ECs (after 2 hrs), while 
increasing pH above 9 favoured desorption of the contaminants. This may be owing to the electrostatic 
repulsion between the negatively charged ECs ions and the PG nano-sheet covered with negative hydroxide 
ions. This hypothesis was confirmed via testing the zeta potential of PG, which varies from -20 to -45 mV 
by increasing the pH of PG suspension as reported by us [36]. A previous study investigated IBP removal 
by GO nanoplatelets (GONPs) has shown the increase in the treatment efficiency by increasing the pH 
value, while the removal efficiency was drastically reduced at higher pH values (>8) [18]. Additionally, 
adsorption of the beta-blocker ATL on GO was reported to have an identical reaction to the pH change 
similar to the one given in this study by PG [31]. The highest pharmaceutical removal was achieved at 
strong acidic conditions (pH 2).  When the pH value increased from 2 to slightly acidic condition (pH 5) 
and then to an alkaline condition (pH 8), the removal of ATL decreased. This desorption behaviour can be 
used to plan a route for regenerating spent PG nano-sheets to reuse them several times in water treatment. 
Fig. 4. Effect of pH on ECs adsorption onto PG (Experimental conditions: 5 mg PG dosage, 20 mL EC of 10 mg/L, 




3.1.5 Temperature variation effect and thermodynamic modelling 
The effect of solution temperature on the behaviour of ECs adsorption onto PG was studied (Fig. 5).  
Generally, raising the solution temperature led to significant increases in contaminant concentrations and 
decreases in adsorption of pharmaceutical pollutants from their solutions by PG. Thermodynamic 
parameters of EC adsorption behaviour were estimated according to equations discussed in SI 1.3. By 
plotting ln D vs. 1/T (Eq. (S16)) for the adsorption of ECs by PG, straight lines were obtained (Fig. S2), 
with correlation coefficients given in Table 4. The calculated thermodynamic parameters (in Table 4) reveal 
more information about the nature of the adsorption process between ECs and PG and determine the 
feasibility and spontaneity of the adsorption process. The negative values of ΔH confirm the exothermic 
nature of the adsorption, which explains the decrease in adsorption at higher temperatures. The magnitude 
of ΔH suggests a weak type of bonding between ECs by PG, such as physical adsorption (ΔH range between 
-20 to -40 kJ/mol), rather than chemical adsorption (ΔH range between -400 and -80 kJ/mol) [57]. The 
negative values of ΔS, suggest a decrease in randomness attributed to the decrease in the degree of freedom 
of pharmaceutical molecules. The free energy change, ΔG, is negative, for a product-favoured and 
spontaneous reaction and an indication of an enthalpy-driven process. 
Fig. 5. Effect of temperature on ECs adsorption onto PG (Experimental conditions: 5 mg PG dosage, 20 mL EC of 10 
mg/L, 2 hr contact time, 200 rpm stirring speed). Error bars indicate standard error of three replicates. 
Table 4. Thermodynamic parameters for the adsorption of ECs onto PG. 
The results of the thermodynamic analysis presented in this study are in agreement with previous studies 
that investigated the sorption of different pharmaceutical pollutants onto graphene and graphene oxide 
nanoplatelets [18, 51]. For instance, aspirin, acetaminophen, and caffeine adsorption by graphene 
nanoplatelets (GNPs) and IBP removal by GONPs were tested at different temperatures [18, 51]. The 
feasibility and spontaneity of both adsorption processes were described by thermodynamic analysis. In both 
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aforementioned reports, the rise in temperature led to a decline in the sorption process, indicating a 
physisorption process which was exothermic in its nature. 
3.1.6 Recyclability of PG 
Recyclability experiment was carried out to demonstrate the reusability of PG. The conditions were 
assigned according to the previous investigations on the effect of pH and temperature variations. The PG 
particles were recycled four times after regeneration via heating at 90 °C in a basic solution of 1 M NaOH 
and then washing repeatedly with water and ethanol. The shown graph in Fig. 6 illustrates the recyclability 
of PG in the ECs uptake process. The graphene material showed reasonable EC removal capabilities with 
recycling for a number of cycles without any major loss in sorption. In these cycles, the removal efficiency 
suffered a little decrease, which was most likely due to an incomplete regeneration process and adsorbent 
mass loss. Mainly, the loss in adsorbent quantity was due to unsettled nanoparticles, which occurred during 
the repeated settling processes of PG. Therefore, the loss in ECs removal efficiency after four consecutive 
adsorption-desorption cycles was about 10% drop in its absolute value as seen from Fig. 6.  
Fig. 6. Recyclability of PG for the adsorption of ECs (Experimental conditions of adsorption test: 5 mg PG dosage, 
20 mL EC of 10 mg/L, 2 hr contact time, 200 rpm stirring speed). 
A limited number of studies investigated the desorption characteristics and recyclability of GBMs, 
adsorbing these ECs from their aqueous solutions [18, 34]. Graphene oxide nanoplatelets (GONPs) were 
reused for 10 cycles to remove IBP from water and regenerated by treating with 4.0 M HNO3 [18]. The rate 
of IBP removal by GONPs attained values above 95%. In a different report, partial CBZ recovery (about 
26%) from graphene oxide occurred by repeated washings with water for eight desorption cycles [34]. It 
was assumed that chemisorption could occur and covalent bonds might be formed between the functional 
groups on the organic chemical CBZ (amide group) and OCFGs on GO. However, the reusability of GO 
was possible by desorbing CBZ with ethanol, resulting in a CBZ recovery of about 93% detected in three 
cycles. This observation showed the physisorption process of CBZ adsorption onto GO. Similarly, the 
physisorption of the six targeted ECs onto PG was detected and revealed in this study by different analytical 
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methods, such as analysis of adsorption isotherm models and thermodynamic analysis of temperature 
variation. 
According to our previous report, PG has proved superior regeneration, cycling efficiency (over 90% as 
treatment efficiency after 5 cycles) and suitability for the decontamination of several target contaminants 
[36]. In fact, the capacity of PG for oil adsorption could last with treatment efficiencies above 90% even 
after 15 cycles. Arsenic, dyes (methylene blue and rhodamine B), fluoride and nitrate were subsequently 
adsorbed by PG and recovered. The adsorption capacities of PG for inorganic and organic contaminants 
were slightly affected after 5 cycles, losing 10% of the total treatment efficiency. In this study, the same 
behaviour was observed with ECs related to the organic group. These results emphasise on the 
experimentally-proved recyclability of the PG material. Optimisation strategies could be implemented in 
future works to investigate the optimum conditions for PG regeneration for more cost-effective recycling. 
For instance, preliminary recyclability tests showed the effect of temperature rise (from 50 oC to 90 oC) was 
not significantly high on ECs desorption from PG. In addition, the amount of washing liquid contributed 
considerably in PG regeneration. 
3.2 Material characterisation and adsorption mechanism 
Material characterisation was performed pre- and post-EC treatment to elicit more insights into adsorption 
properties of sorbents and the sorption mechanism. Surface morphology and composition of the 
investigated materials were discussed as below, while their specific surface area, particle size, surface 
charge, and surface wettability were shown in SI 2 (Further investigation on properties of GBMs and ECs). 
3.2.1 Surface morphology  
The surface features of GI, as-prepared GO and PG were examined using SEM and are shown in Fig. 7 and 
Fig. S3. Raw material GI particles exhibited flaky texture (Fig. 7A and Figs. S3 (a, b)). After the oxidation 
of these GI flakes and consequent exfoliation of their resultant particles, GO was prepared, showing a 
noticeable sheet-like layered structure (Fig. 7B and Fig. S3 (c,d). The material developed in this study (PG) 
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has a nanostructural morphology, which has evidently been supported by pore size using surface 
characterisation analyser (4 nm as average pore size, Table S4 in SI 2.1). However, partial agglomeration 
and stacking was observed in GBMs, especially between PG nanosheets. Due to their small cross sectional 
sizes and high specific surface area (Table S4), PG nanosheets were more prone to aggregation and 
clustering (Fig. 7C and Fig. S3 (e, f)).  Wrinkles, defects and corrugations are visualised in GO and PG 
nanosheets in SEM images, which are revealed more clearly by high-resolution TEM images (Figs. S4 and 
S5). The structure of PG was revealed as a transparent irregular, folded nanosheets interweaved with each 
other. The formation of nano-sized channels or pores < 5 nm on PG surface was confirmed (Fig. 7D).  
The composition of adsorbents was detected prior to adsorption experiments using energy dispersive X-ray 
spectroscopy attached to SEM and TEM instruments. Results are given in Figs. S6 and S7 and Table S3. 
Graphite was almost 99% carbon with some traces of oxygen, while GO had a higher oxygen content, 
attesting the presence of OCFGs and a carbon-to-oxygen ratio of 2.6 on average. PG had a majority of 
carbon content, but still some OCFGs were available in its composition to a certain extent. Regarding the 
composition of elements in the spent particle of PG post adsorption with ECs, Table S3 lists the elemental 
composition (%) of carbon, nitrogen, oxygen, fluorine and chlorine. The obtained results agreed with the 
elements found in the structural formula of pharmaceutical compounds in Table 1. According to Table S3, 
C, O and N were presented in ATL-PG and CBZ-PG spent; C, N, O and F or Cl were detected in CIP-PG 
and DCF-PG spent, respectively; and GEM-PG and IBP-PG contained C and O only. This detection proved 
the occurrence of adsorption process on the sheet surface of PG and made these samples reliable for further 
investigations using XRD, FT-IR and Raman spectroscopy for more insights into the adsorption 
mechanism.  




3.2.2 Surface composition 
Material properties of PG were inspected before and after adsorption of ECs to elucidate the adsorption 
mechanism. Prior to adsorption experiments, adsorbents were characterised using X-ray diffraction and FT-
IR spectroscopy and their patterns are presented together in Fig. S8. Each adsorbent exhibited its 
characteristic peaks at 26o (2θ) for GI, 12.6o for GO and 24.4o for PG [36]. In comparison to these XRD 
patterns, it is observed the broadening of (002) lattice peak for PG and reduction of its intensity compared 
to that of graphite, and this is an indication of graphene sheet formation. After adsorption of EC by PG, 
there was no significant change in the patterns shown in Fig. S9. Identical diffraction patterns were 
developed, indicating no considerable alteration in crystal structure and composition. Regarding FT-IR 
patterns, Fig. S8b presents characteristic bands of distinguishable functional groups; 1052, 1246, 1384 cm−1 
(C–O stretching in epoxy group),1627, 1678, 1732 cm−1 (C=C stretching in aromatic ring), 2362 cm−1 (C=O 
stretching in carboxylic acid), 2849, 2922 cm−1 (C–H stretching vibrations) and 3444 cm−1 (O–H stretching 
vibrations) [31, 39]. Graphs presented in Fig. 8 include the FTIR spectra of ECs, which have a strong peak 
at 3356 cm−1 (for ATL) ascribed to N–H skeletal vibrations of both primary and secondary amine (–NH2 
and –NH), and a medium peak at 3172 cm−1 owing to hydrogen bonding of O–H stretching and at 3434 
cm−1 corresponding to free O–H stretching vibrations [31]. Moreover, C=O, C=C and C–O–H stretching 
vibrations were found at several positions, e.g., at 1638 cm−1, 1582 cm−1 and 1417 cm−1, respectively. The 
FTIR spectra of PG before and after EC adsorption revealed that although most of the peaks of EC were 
not observable after EC adsorption, the peaks corresponding to the stretching vibration of C=C bonds 
shifted from 1630 to 1633, 1637, 1634 cm-1 after ATL, CBZ and CIP adsorption, respectively, and to 1638, 
1637, 1636 cm-1 after DCF, GEM and IBP adsorption, respectively. In agreement with previous findings in 
different reports [36, 38, 39], the peak shift, in this case, portrays the role of π-π interaction between EC 
and PG in the adsorption process. Other small shifts were recorded elsewhere around peak regions, 
identifying O–H stretching vibrations for ATL, GEM and IBP adsorption, showing that PG interacted with 
some ECs via a few hydrogen bonds. In general, some peaks of FT-IR spectrum of PG after adsorption 
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were clearly shifted, indicating that the functional groups of PG were still remained. However, ascribed to 
physisorption, the bands appeared weakened and broadened after adsorption in Fig. 8.  
Fig. 8. FT-IR spectra of PG before and after adsorption of the pharmaceutical contaminants (Adsorption conditions: 
10 mg/L solution, 250 mg/L PG dose). 
On the other hand, Raman spectroscopy was conducted for the qualitative analysis of graphene before and 
after adsorption of ECs (Figs. S11 and S12 ). Peaks of Raman patterns for PG are not shown clearly in Fig. 
S12 due to the high intensity of bands exhibited by all ECs. The plots of Raman spectra of ECs of our 
particular interest depicted their features, representing distinct bond types and the availability of different 
bonding sites for possible interactions with adsorbents. In Fig. S11, a more illustrative Raman pattern for 
PG showed peaks of G and D bands [58]. The band shape of 2D was distorted which caused its broadening, 
giving a particular evidence for Bernal stacking of layers that is witnessed in exfoliated graphene. The 
Raman G-peak was detected at ca. 1577 cm−1 and was indicative of the sp2-hybridized hexagonal lattice of 
carbon atoms that represented defects on the edges of the graphene, while the D-peak was located at ca. 
1330 cm−1, which corresponds to sp2-hybridized hexagonal lattice of carbon atoms [59, 60]. The ID/IG ratio 
of as-prepared pristine PG was almost equal to unity, providing that the activation of nanosheets for the 
formation of pores and edges in the PG layers occurred ascribed to the increased amount of sp3-hybrdized 
carbon atoms. Small shifts in G and D bands and generation of new bands at around 558, 785, 950 and 1088 
cm-1 were found in Raman spectra of spent PG post adsorption of ECs (Figs. S11 and S12). These new 
patterns resembled the intercalation of EC molecules in the inter-layer space of PG. In addition, the 
existence of new bands in the region of relatively lower frequency vibrations suggested the formation of 
weak bonds might be as a result of π-π interactions, hydrogen bonding and van der Waals (vdW) forces.  
3.2.3 Adsorption mechanism 
Based on the aforementioned analyses and discussions, this section summarises the findings extracted from 
characterisation of materials pre- and post-adsorption, adsorption isotherm and thermodynamic studies. The 
following dominant adsorption mechanisms were deduced at several points of this study from the low 
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absolute values of ΔH in thermodynamic studies, from low values of main energy of adsorption in D-R 
model, and from analysing spent PG using FT-IR analysis and Raman spectroscopy. Firstly, PG had several 
types of OCFGs, such as (such as carboxylic (–COOH), hydroxyl (–OH), and epoxy (–C–O–C–)) and active 
sites arising from the abundance of porous architected channels on its large surface area. Taking that into 
account, the affinity in the adsorption process between PG and contaminants having different sizes relied 
on the high surface area, porous structure and availability of significant transformation sites. Secondly, the 
surface charge and protonation-deprotonation transition of functional groups on the active sites of the PG 
surface under different pH conditions play a crucial role in the adsorption process. Pharmaceutical with 
both primary amine (–NH2) group, such as ATL and CBZ, and secondary amine (–NH) group, such as CIP 
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Electrostatic interactions could occur between mainly the protonated amine groups −NH3
+ and between the 
negatively charged groups of PG (e.g., –COO-) as in Eq. (1). Additionally, surface-bridging via H-bonding 
could possibly exist between the hydrogen atoms of hydroxyl groups of PG and nitrogen atoms of amine 
groups of drug molecules (Eqs. (2, 4)) or the oxygen atoms of hydroxyl groups of PG and hydrogen atoms 
of amine groups of drug molecules (Eqs. (3, 5)). Also, hydrogen bonding could take place between all of 
pharmaceuticals and PG as follows (Eqs. (6, 7)): 
 PG−COOH+ Drug= O
 Hydrogen bonding  




 Hydrogen bonding  
→               PG − OH ⋯O = Drug      (7) 
Moreover, hydrophobic effects and π–π interactions between the localized π electrons in the conjugated 
aromatic rings of the PG and the pharmaceutical molecules could contribute to the adsorption mechanism. 
PG  +   -Drug
 π–π interactions   
→              PG -  -Drug     (8) 
 Other weaker interactions such as van der Waals forces could exist as well. And all these suggested 
interactions are in a reasonable agreement with similar effects and interactions previously reported for the 
adsorption of different ECs on GO materials [18, 28, 31, 32, 34].  
It becomes obvious how drugs such as CBZ and CIP can be readily adsorbed by PG (Fig. 1 and Table S2). 
For instance, the presence of three aromatic rings, primary amine group and carbonyl group in CBZ 
structure (Table 1) offered more than three types of interactions. Especially under acidic conditions 
(pH<pKa, acidity constant pKa of CBZ=13.9), drug molecules existed in positively charged form due to 
the ease of NH2 protonation. Comparatively, PG exhibited a negative charge state for the particles at all 
tested pH conditions as stated previously. Therefore, electrostatic and π–π interactions along with hydrogen 
bonding, and van der Waals (vdW) forces are all presented in the adsorption mechanism, resulting in high 
uptake by PG and fast kinetics. The hydrophobic nature of the drug also plays a vital role in adsorption via 
hydrophobic effects developed between drug molecules, PG sheets and water. 
Carbonaceous compounds (PG, GO and GI) exhibit nearly the same aforementioned adsorption 
behaviour/mechanism towards the targeted contaminants, so electrostatic interactions, hydrogen bonding, 
π-π interaction and van der Waals (vdW) forces, all could exist in the adsorption mechanism but with a 
varying degree. This degree depends on the number of OCFGs on the adsorbent surface (high in the case 
of GO or very low for GI). Therefore, electrostatic and π-π interactions could dominantly occur between 
hydrophobic organic groups/molecules of the pollutants and carbon sheets of PG. 
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3.3 Water treatment potential of PG as a nano-adsorbent 
Through the included investigations of this study, PG has proved its reliability for ECs removal from water 
and wastewater. Besides, PG could have higher adsorption capacities for conventional and emerging 
contaminants if applied in treatment works compared to ligand-based composite materials available in the 
literature [61]. According to our previous report, PG has shown its efficacy in eliminating arsenic, fluoride, 
nitrate, methylene blue, rhodamine B and oil from water [36]. For instance, the adsorption capacity of PG 
for arsenic exceeded 325 mg/g more than the reported values (82.40 mg/g or 142.25 mg/g) for some ligand-
functionalized nano-conjugate materials [61, 62].  The determined adsorption capacities of our suggested 
material (PG) in single adsorption experiments were 325, 375, 500, 313 and 375 mg/g-PG for arsenic, 
fluoride, nitrate, methylene blue, and rhodamine B, respectively [36]. Besides, PG has great values of 
pharmaceutical adsorption capacity often greater than those of other reported carbonaceous counterparts 
according to Table S2. Comparing these results with those in previous reports, Banerjee et al. prepared 
GONPs and investigated them for the adsorption of IBP from its aqueous solution, achieving a maximum 
adsorption capacity of only around 3.24 mg/g [18], while Kyzas et al. removed the beta-blocker ATL by 
GO with a maximum adsorption capacity of 116 mg/g [31]. GO was utilised to remove DCF and CIP with 
maximum adsorption capacities of 43.9 mg/g [32] and 379 mg/g [33]. Carboxyl-functionalised multi-walled 
carbon nanotubes (MWCNTs) and GAC possessed adsorption capacity for CBZ of around 120 and 50 
mg/g-sorbent, respectively [34]. Concerning graphene, Zhu et al. sorbed CIP onto graphene with a 
maximum adsorption capacity of 323 mg/g-G [39]. This value is close to that estimated in this current study 
for the maximum achieved adsorption capacity of PG for CIP in experiments (329 mg/g, Table S2) and 
slightly lower than that maximum adsorption capacity calculated according to Sips isotherm model (370 
mg/g, R2=1, Table 3). GAC was tested in the same study for CIP removal with a maximum adsorption 
capacity of 217.4 mg/g-GAC [39]. The maximum adsorption capacity for the adsorption of DCF by reduced 
graphene oxide (rGO) was reported as 59.67 mg/g [38]. From Table S2 and 3, the maximum recorded 
adsorption capacities of PG for DCF in experiments is 76 mg/g and, according to Langmuir, Toth and Sips 
adsorption models, are ca. 91.6 (R2=0.963), 82.74 (R2=0.974) and 75.8 (R2=1), respectively. rGO had a 
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much lower specific surface area (98 m2/g) compared to that of suggested PG (ca. 670 m2/g), which justifies 
the outperformance of PG in this study. Direct literature might not be available for the rest of the selected 
ECs removed by graphene. 
Despite the extensive research into the graphene development for a variety of applications, the safety and 
environmental toxicity of graphene have been an issue for the safe and sustainable translation of graphene 
into an array of industrial markets. Our research group (Prof. Zhang) has extensively studied the toxicity, 
toxicokinetics, underlying toxicology mechanisms and influencing factors of graphene nanostructures 
towards the environment and living systems at cellular and molecular levels [63], such as PG foam [64], 
GO [65], rGO [66], PG [67] and graphene quantum dots [68]. Additionally, they have also studied the 
release of any toxic ions, free radicals, or unpaired electrons from graphene structures towards living 
systems in a dose- and concentration-dependent manner. These studies provide key insights into the 
transportation and uptake of PG architectures into the aquatic environment causing minimal levels of 
toxicity over 7 days of interaction of graphene with fish (as an aquatic animal model). It was concluded that 
porous architectures of graphene did not impose any potential threat to the aquatic organism, food uptake, 
and eventually to human health. Although long-term toxicity of graphene has not been explored yet. 
However, in water treatment systems, the use of graphene is time-specific which implies that limited 
concentration and dosage patterns of graphene are likely to be safe for aquatic organisms. Collectively, our 
group has illustrated that via tuning the physio-chemical features and surface properties of graphene 
nanostructures, environmental and biological safety of graphene can be improved in a dose- and time-
dependent manner. While at low doses (such as 10 mg/ml concentration), graphene has been found less 
toxic and compatible with living systems [63, 67]. In the current study, concentrations of 250 mg/L (on 
average) were used which are unlikely to have any noticeable toxic effects towards human and animal cells, 
organs, and tissues. These findings allow for the application of these graphene nanostructures in the 
environmental industry, including water and wastewater treatment. 
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The interaction of graphene with living systems in wastewater treatment applications is likely to be non-
invasive in general. Such non-invasive interactions relatively induce less toxicity in comparison to other 
administration routes of graphene (intravenous) in the living systems for disease management (such as 
drug/gene delivery and light-mediated theranostic applications) [69]. While in water and wastewater 
treatment modalities, graphene-based absorbents are being used in treatment plants as an ‘indirect’ 
interaction with living systems. After the purification of water (and wastewater) with graphene, it is 
significantly important to evaluate whether treated water contains any graphene-related toxic ions. Potential 
risks resulting from the release of any toxic ions from graphene need to be evaluated. In the current work, 
using a wide range of analytical tools, PG structures were investigated before and after adsorption, revealing 
that graphene did not release any toxic ions. Additionally, the reuse, regeneration, and recyclability of 
graphene were investigated which also showed that graphene mass was not reduced up to toxic levels. 
Acute, sub-chronic, and chronic levels of toxicity are associated with invasive use (delivery, and 
implantation) and administration routes of graphene. Using such administration routes, the notions of 
biotransformation, bioaccumulation, biomagnification, biodistribution, and biosafety of graphene can be 
investigated by evaluating the toxicity levels in biological fluids and organs (such as heart, kidney, lungs, 
liver). These organs reveal the clearance and biodistribution of graphene in animal and human models [69, 
70]. As discussed earlier in this section, our group has recently investigated the biosafety of graphene 
nanostructures at cellular, tissue, and organ levels, revealing that the toxicity of graphene is dose-, time- 
and administration route dependent [63-68]. Taken together, the production route reported in this work 
enables the sustainable development of PG into water treatment applications. In addition, further research 
work is needed to fully elucidate the ecotoxicity of these materials associated with water treatment plants. 
These future studies may support the regulatory decision making and risk assessment for the successful 
realisation of PG-based materials into environmental applications. 
Economically, PG is a cost-effective and environmentally friendly material of proved recyclability [36, 49, 
71]. The facile production route stated for this superhydrophobic PG (based on heat treatment of rGO) was 
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to unlock the current main bottlenecks in its commercial application. This thermal treatment process 
involved temperature range 190–200 °C, which was lower than that previously reported for the porous rGO 
synthesis (800 °C) [37]. More developments are possible for further improvements. For instance, the 
synthesis process mentioned in this study could be altered to follow a green approach based on iron-based 
graphene oxide synthesis and coconut oil reduction [71, 72]. The produced rGO could be further thermally-
treated at relatively low temperature as a key feature (discussed in this study and our previous study [36]) 
to produce highly porous graphene of higher specific surface area. This modified process is non-toxic, 
ultrafast (<1 h preparation), safe and cheap (without sonication and with ease of separating the final 
product). Furthermore, PG nanosheet could be utilised as a reliable supporting material for various 
nanoparticles via cross-linkers to form novel evolutionary nanocomposites that act as a platform for 
environmental applications [49, 73, 74].   
The removal technologies in tertiary treatment units are mainly responsible for eliminating ECs and, in 
particular, pharmaceutical contaminants. However, various studies have shown that the most common 
tertiary treatment technologies, such as granular activated carbon (GAC) and ozone treatment, could not 
eliminate efficiently resisting pharmaceutical compounds [25]. CBZ and GEM were among this list that 
resists treatment because of their physicochemical properties such as high water solubility and/or poor 
degradability [75]. In this study, PG showed high adsorption capacities for CBZ (154.25 mg/g, Sips model, 
R2=1, Table 3) and GEM (40 mg/g, Table S2), fast kinetics (Fig. 1) and reliable performance in treating 
these contaminants in water and actual wastewater bodies spiked with single or mixed ECs solution (Fig. 
3). Another issue, activated carbons have been investigated as an efficient adsorbent for the removal of 
pharmaceutical and personal care products (PPCPs), such as p-Chloro-m-xylenol [76], diclofenac, 
ibuprofen, ketoprofen, and naproxen [2, 77] and triclosan [78]. However, regeneration of activated carbons 
(ACs) after adsorption is difficult, making the adsorption using ACs costly, not reliable and not applicable 
to large-scale treatment processes [79].  Reused and modified ACs have removal efficiencies below 40 % 
that of the original [80]. Thus, it is imperative to seek another more efficient adsorbent to replace ACs. 
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Based on the all aforementioned benefits and real samples investigations, PG-based materials are 
recommended for applications in wastewater treatment plants as a tertiary treatment option (such as filter 
media and continuous mixed systems) to remove ECs from water.  
4 Conclusions 
The growing use of pharmaceutical compounds and products classified as emerging contaminants (ECs) 
has recently raised great environmental concern worldwide. Driven by these environmental concerns, this 
study was aimed to evaluate the adsorption performance of porous graphene (PG), and compare it with 
other carbonaceous materials (graphene oxide (GO) and graphite (GI)), as a potential candidate to remove 
a range of extensively used pharmaceuticals (atenolol (ATL), carbamazepine (CBZ), ciprofloxacin (CIP), 
diclofenac (DCF), gemfibrozil (GEM) and ibuprofen (IBP)) from water and wastewater. This study 
revealed i) fast adsorption kinetics of ECs onto PG guided by pseudo-second order model and adsorption 
capacities exceeding 100 mg-EC/g-PG for some of ECs; ii) high removal efficiencies for trace 
concentrations of ECs (>99.9%) at a low dose of PG (100 mg/L); iii) multilayer and heterogeneous 
adsorption processes mainly followed the Toth and Sips adsorption isotherm models and controlled by 
physisorption mechanism, including electrostatic and π-π interactions, hydrogen bonding, and Van der 
Waals forces; iv) the robust adsorption performance of PG in real sample investigations, removing 99% of 
ECs in mixed solution systems at low dosages (250-500 mg/L); and v) the exothermic nature of the 
enthalpy-driven adsorption process (credited to negative values of the thermodynamic parameters), and 
confirmed the physical adsorption mechanism (ΔH values>-60 kJ/mol). Finally, PG had a good 
recyclability potential, which was demonstrated after its regeneration and reuse for four cycles in treating 
pharmaceutical-contaminated solutions. Further investigations are required to study the performance of 
these graphene-based materials as filter media for the removal of these ECs from surface waters and 
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 Adsorption mechanisms of 6 emerging contaminants (ECs) on porous graphene (PG) were 
revealed. 
 The heterogeneous adsorption was mainly described by Toth and Sips isotherm models. 
 PG’s treatment efficiency for ECs mixture was broadly robust in real samples studies.  
 Decontaminating ECs trace concentrations reached > 99% at a low dose of PG.  
 PG showed a promising recyclability potential for the 6 ECs (10% drop after 4 cycles). 
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Fig. 1. Effect of contact time on adsorption of ATL, CBZ, CIP, DCF, IBP and GEM onto GI, GO and PG. 
Error bars were calculated based on standard deviation (Experimental conditions: number of runs 3; C0 10 
mg/L; adsorbent dosage 250 mg/L; pH 7.5; temperature 22 ± 3 oC). Graph dots and lines represent 
experimental results and their moving average fitting, respectively, and error bars indicate standard error 






































































































































































































































Fig. 2. Adsorption isotherms of six investigated ECs onto G, GO and PG. Solid lines represent suggested 
model simulation. Experimental conditions: 250 mg/L adsorbent, pH 7.5, temperature 22 ± 3 oC. Error bars 
indicate standard error of three replicates. 
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Fig. 3. Effect of adsorbent dosage on the removal of EC in distilled water and wastewater bodies (single or 
mixed solution, contact time: 24 hrs; pH (DW) 7.5; pH (WW) 7.1; initial individual EC concentration in 
single or mixed solution: 1 mg/L). Error bars indicate standard error of four replicates.  
 
Fig. 4. Effect of pH on ECs adsorption onto PG (Experimental conditions: 5 mg PG dosage, 20 mL EC of 





























































Fig. 5. Effect of temperature on ECs adsorption onto PG (Experimental conditions: 5 mg PG dosage, 20 











Fig. 6. Recyclability of PG for the adsorption of ECs (Experimental conditions of adsorption test: 5 mg PG 






















































Fig. 7. SEM Images of (A) GI, (B) GO and (C) PG. (D) High-resolution TEM image of PG showing 




































Fig. 8. FT-IR spectra of PG before and after adsorption of the pharmaceutical contaminants (Adsorption 
conditions: 10 mg/L solution, 250 mg/L PG dose). 
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 Table 1.  Target compounds and their structures, main m/z ions, fragmentor and collision energy voltages, average 
retention time and limits of quantification (LOQ) for LC-MS analysis. 
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Atenolol  267.2 145.1 190.1 100 29 & 17 1.71 0.24 
Carbamazepine  237.1 194.1 179.1 140 21 & 35 2.58 0.12 
         
         
         
Ciprofloxacin  332.1 288.2 314.1 100 17 & 21 5.28 0.98 
         
         
         
Diclofenac  296.0 214.1 250.0 80 35 & 9 7.03 0.24 
         
         
         
Gemfibrozil  251.2 129.1 55.1 60 9 & 33 7.41 3.91 
         
         
         
Ibuprofen  207.1 161.0 119.1 60 9 & 21 6.63 15.63 
         
Table 2. Values of fitted kinetic parameters for ECs adsorption by PG and GO (10 mg/L initial EC concentration, 









Pseudo second-order parameters 
 
Elovich equation parameters 
 
Intra-particle diffusion 
equation Parameters       
   
k1 
(min-1) R2   qe(mg/g) k2 (g/(mg.min)) R2  a (mg/(g.min)) 
b 




(mg/g) R2  
ATL-PG  0.0089 0.995   36.55 0.00012 0.99  0.423 0.148 0.99  1.265 -1.224 0.976  
                   
ATL-GO  0.0099 0.772   16.12 0.01211 0.99  15.134 0.396 0.61  1.076 5.352 0.805  
                   
CIP-PG  0.0126 0.834   40.88 0.00205 0.99  157.088 0.233 0.84  1.733 15.740 0.644  
                   
CIP-GO  0.0144 0.434   41.78 0.01543 0.99  9.12E+98 5.725 0.09  1.327 25.898 0.305  
                   
CBZ-PG  0.0104 0.779   35.31 0.00241 0.99  8174.061 0.418 0.83  1.351 15.421 0.559  
                   
CBZ-GO  0.0087 0.985   4.76 0.00212 0.91  0.125 1.115 0.91  0.217 -0.0178 0.991  
                   
IBP-PG  0.0111 0.405   29.44 0.00604 0.99  556522.223 0.636 0.78  1.088 15.036 0.462  
                  
IBP-GO  0.0073 0.912   7.96 0.00046 0.61  0.096 0.841 0.91  0.262 -0.396 0.928  
                  
DCF-PG  0.0057 0.517   30.62 0.00491 0.99  305.819 0.318 0.81  1.420 13.082 0.641  
                   
DCF-GO  0.0086 0.761   31.11 0.00321 0.99  31.141 0.235 0.94  1.520 11.021 0.743  
                   
GEM-PG  0.0095 0.566   28.98 0.00544 0.99  6595.591 0.475 0.89  1.128 13.881 0.516  
                   












Table 3. Equilibrium parameters for the adsorption of ATL, CIP, CBZ, IBP, DCF and GEM onto PG and GO. 
Experimental conditions: 250 mg/L adsorbent, pH 7.5, temperature 22 ± 3 oC. 
Experiment  
Freundlich model Parameters 
 
Langmuir model Parameters 
 
Tempkin  model Parameters 
 
D-R  model Parameters 
      
   kF (mg/g) nf R2  qs (mg/g) kL (L/mg) R2  B1 kT (L/g) R2  qs (mg/g) E (kJ/mol) R2 
ATL-PG  2.738 1.071 0.961  8.87 0.445 0.712  21.445 1.75 0.8  33.66 1.38 0.60 
                  
ATL-GO  7.598 1.303 0.946  117.13 0.076 0.867  15.001 3.61 0.88  38.36 1.69 0.91 
                  
CIP-PG  18.5091 0.878 0.697  -7.33 -0.554 0.351  77.066 3.101 1  342.63 1.10 0.88 
                  
CIP-GO  281.77 0.677 0.564  25.62 2.183 0.025  145.711 10.592 0.95  309.71 2.24 0.49 
 
CBZ-PG  12.2785 1.446 0.919  14.63 2.611 0.721  23.618 5.376 0.87  40.17 2.80 0.54 
                  
CBZ-GO  0.864 1.132 0.968  8.89 0.138 0.992  9.611 0.897 0.64  9.77 1.20 0.55 
                 
IBP-PG  6.267 1.339 0.901  47.85 0.175 0.982  7.006 5.801 0.76  21.14 1.95 0.87 
                  




DCF-PG  7.671 1.564 0.761  91.59 0.103 0.963  13.433 4.526 0.98  58.06 1.38 0.98 
 
DCF-GO  3.658 1.139 0.796  2.43 3.064 0.831  7.869 7.387 0.74  8.97 2.91 0.48 
                 
GEM-PG  4.604 0.842 0.865  9.26 0.663 0.530  11.533 2.993 0.75  17.98 1.78 0.55 
                  




Elovich model Parameters 
 
Toth model Parameters 
 
Sips model Parameters 
     
   qs (mg/g) kE (g/mg) R2  qs (mg/g) n KT (mg/g) R2  KS (L/mg) qs (mg/g) z R2 
ATL-PG  385.31 0.007 0.1  1455.36 0.51 0.050 0.984  0.457 71.81 0.916 0.7 
                
ATL-GO  64.73 0.161 0.6  1656.02 0.58 0.053 0.981  0.029 282.8 6.661 0.99 
                
CIP-PG  -115.64 -0.110 0.2  409.15 0.94 0.246 0.995  0.246 370.11 1.239 1 
                
CIP-GO  -79.58 -0.718 0.4  624.10 1.10 1.151 0.970  2.515 417.79 3.541 0.99 
                
CBZ-PG  88.96 0.210 0.6  191.67 0.72 0.242 0.984  0.204 154.251 1.188 1 
                
CBZ-GO  2092.89 0.00034 0  139.80 0.54 0.178 0.841  0.175 27.491 1.067 0.59 
               
DCF-PG  41.23 0.295 0.4  82.74 0.79 0.433 0.974  0.559 75.801 1.970 1 
                




IBP-PG  71.17 0.096 0.1  110.30 0.20 2.037 0.758  0.139 49.508 0.572 0.76 
                
IBP-GO  -20.53 -0.027 0.4  72.87 0.16 1.477 0.794  0.097 18.791 4.869 0.89 
 
GEM-PG  -38.73 -0.081 0.5  160.86 0.815 0.118 0.902  0.134 109.710 1.810 0.92 
                










Table 4. Thermodynamic parameters for the adsorption of ECs onto PG. 
Parameters ATL CBZ CIP DCF IBP  GEM 
R2 of ln D vs. 1/T plot   0.793 0.968 0.922 0.944 0.972 0.939 
ΔH (kJ/mole) -14.371 -25.000 -10.190 -23.380 -53.470 -47.590 
ΔS (kJ/mole.K) -0.039 -0.061 -0.004 -0.057 -0.165 -0.146 
ΔG (kJ/mole) -2.861 -6.471 -8.840 -6.131 -4.051 -3.951 
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